Stay updated with breaking news from Expanded Disability Status Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Although questions remain about ideal treatment strategies, consistent data have shown that patients should be treated early.
The progressive, neurodegenerative disease is estimated to affect more than 130,000 people in the UK
CSF biomarkers collected from a spinal tap around the time of an MS diagnosis may predict disability progression and relapses, per a study.
Among patients with pediatric-onset MS, early administration of high-efficacy therapy is associated with a reduced risk for disability progression.
Link to original article: Foralumab eases fatigue in most SPMS patients in access program Foralumab found to ease fatigue in SPMS patients in access...